Aminophylline dihydrate

This classification denotes the dihydrate form of a phosphodiesterase inhibitor and bronchodilator with the molecular formula 2C7H8N4O2.C2H8N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 27Y3KJK423, chemically known as 3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione but more generally known as aminophylline, which bears US NIH Compound Identifier 2153. Aminophylline most often comes in base, anhydrous, and dihydrate forms. European Medicines Agency schedules Aminophylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05444MIG. The term AMINOPHYLLINE is an International Non-Proprietary Name. World Health Organization schedules aminophylline in its Anatomical Therapeutic Chemical (ATC) Classification. AMINOPHYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule aminophylline dihydrate under HS 29395900 and SITC 54145. As of Q4 2014, AMINOPHYLLINE DIHYDRATE remains US FDA's Preferred Term for this commodity. Aminophylline dihydrate bears US NLM identifiers UMLS ID C3472162 and NCI Concept Code C76313. SMILES: CN1C2C(C(=O)N(C1=O)C)[NH]CN2.CN1C2C(C(=O)N(C1=O)C)[NH]CN2.C(CN)N.O.O.